Clinical Trial Update: Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia [Phase 2, Phase 3]

View source ↗

Summary

This entry reports an update on a Phase 2/Phase 3 clinical trial of gemtuzumab ozogamicin in older patients with previously untreated acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Gemtuzumab ozogamicin (gemtuzumab ozogamicin)

Snippet

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC | Conditions: Leukemia | Phase 2, Phase 3 | Status: UNKNOWN